Senior Scientist and Director
Center for Cancer Research, National Cancer Insitute/NIH
Bethesda, Maryland, United States
Dr. Amy LeBlanc is a board-certified veterinary oncologist, Senior Scientist and Director of the intramural NCI’s Comparative Oncology Program. In this position she conducts preclinical mouse and translational pet dog studies that are designed to inform the drug and imaging agent development path for human cancer patients, specifically those with osteosarcoma. She directly oversees the NCI Comparative Oncology Trials Consortium (COTC), which provides infrastructure necessary to connect participating veterinary academic institutions with stakeholders in drug development to execute fit-for-purpose comparative clinical trials in novel therapeutics and imaging agents. Her program provides support to several extramural NCI-funded initiatives including the Integrated Canine Data Commons and Cancer Moonshot-funded canine immunotherapeutic clinical trials conducted under the PRECINCT network.
Disclosure information not submitted.
The NCI-COP COTC033a/b Clinical Trial: Repurposing Vaccine Immunity to Treat Cancer
Friday, June 20, 2025
8:00 AM – 9:00 AM ET